Meropenem

Alternative Names: Merrem, Merrem IV

Meropenem is a broad-spectrum carbapenem antibiotic used to treat serious bacterial infections, including severe aspiration pneumonia. It provides excellent coverage against gram-positive, gram-negative, and anaerobic organisms, making it especially useful when complications such as lung abscess, empyema, or necrotizing infection are suspected. Compared with imipenem-cilastatin, meropenem is generally better tolerated and carries a lower risk of seizures, particularly in patients with renal impairment or CNS disease. Because of its potency, meropenem is typically reserved for critically ill or hospitalized patients, while narrower agents are preferred for uncomplicated cases.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Meropenem

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Meropenem appears to be an effective treatment for aspiration pneumonia, especially in complex cases involving critically ill patients or those with potential complications like abscess or empyema. It provides broad-spectrum coverage against resistant gram-negative organisms and anaerobes, and has a lower seizure risk compared to similar antibiotics, making it a valuable option in certain clinical scenarios.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
0
1 = Very Expensive 5 = Very Affordable

0

Very Expensive
Relief Speed
4.0
1 = No Relief 5 = Immediate Relief

4.0

Fast Relief
Side Effects
3.0
1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Meropenem appears to be an effective treatment for aspiration pneumonia, especially in complex cases involving critically ill patients or those with potential complications like abscess or empyema. It provides broad-spectrum coverage against resistant gram-negative organisms and anaerobes, and has a lower seizure risk compared to similar antibiotics, making it a valuable option in certain clinical scenarios.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 month ago
Meropenem is selected for aspiration pneumonia when very broad coverage is needed, including resistant gram-negative organisms and anaerobes. It is particularly valuable in critically ill patients or when complications such as abscess, empyema, or necrotizing infection are suspected. Compared with imipenem, meropenem has a lower risk of seizures, making it safer in patients with renal impairment or CNS disease.
#FastRelief #ModerateEffect #Second-line #Rescue/EmergencyUse
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All